30 related articles for article (PubMed ID: 2967737)
1. In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K; Fernandez HT
Antimicrob Agents Chemother; 2003 Jun; 47(6):1968-71. PubMed ID: 12760876
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of synercid and related drugs against Streptococcus oralis isolated from septicaemia and endocarditis cases.
Rafay AM
J Sci Res Med Sci; 2000 Jan; 2(1):25-31. PubMed ID: 24019702
[TBL] [Abstract][Full Text] [Related]
3. Comparative hydrodynamic and nanoscale imaging study on the interactions of teicoplanin-A2 and bovine submaxillary mucin as a model ocular mucin.
Chun T; Pattem J; Gillis RB; Dinu VT; Yakubov GE; Corfield AP; Harding SE
Sci Rep; 2023 Jul; 13(1):11367. PubMed ID: 37443326
[TBL] [Abstract][Full Text] [Related]
4. Microbiological profile of teicoplanin.
Covelli I; Nani E
J Chemother; 1991 Jan; 3 Suppl 1():39-42. PubMed ID: 12041783
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.
Ravizzola G; Pirali F; Foresti I; Turano A
Drugs Exp Clin Res; 1987; 13(4):225-9. PubMed ID: 2957187
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.
Robbins MJ; Marais R; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1987; 13(9):551-4. PubMed ID: 2962846
[TBL] [Abstract][Full Text] [Related]
7. Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates.
Streit JM; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2004 Feb; 48(2):137-43. PubMed ID: 14972384
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT
Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vitro activity of teicoplanin against recent clinical isolates.
Nani E; Amato G; Anzivino D; Covelli B; Lembo M
Chemioterapia; 1988 Feb; 7(1):20-3. PubMed ID: 2967737
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Campoli-Richards DM; Brogden RN; Faulds D
Drugs; 1990 Sep; 40(3):449-86. PubMed ID: 2146108
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
